TFC241101P35000
- 0.03
- 0.000.00%
Truist Financial Newsroom
Truist Financial Sticks to Their Hold Rating for Edwards Lifesciences (EW)
Truist Financial Sticks to Its Buy Rating for Tourmaline Bio (TRML)
Truist Financial Remains a Buy on International Paper Co (IP)
R1 RCM (RCM) Receives a Hold From Truist Financial
Brandywine Realty (BDN) Receives a Buy From Truist Financial
Truist Financial Reaffirms Their Buy Rating on Avery Dennison (AVY)
Truist Financial Gives a Buy Rating to Edgewise Therapeutics (EWTX)
GE Vernova Inc. (GEV) Receives a Buy From Truist Financial
Truist Financial Remains a Buy on First Solar (FSLR)
Truist Financial Reaffirms Their Buy Rating on Central Garden Pet (CENT)
Truist Financial Remains a Hold on Bloom Energy (BE)
A Quick Look at Today's Ratings for Truist Financial(TFC.US), With a Forecast Between $47 to $49
Truist Financial Price Target Raised to $46.00/Share From $45.00 by RBC Capital
Truist Financial Is Maintained at Outperform by RBC Capital
Truist Finl Analyst Ratings
A Quick Look at Today's Ratings for Truist Financial(TFC.US), With a Forecast Between $46 to $49
Morgan Stanley Adjusts Price Target on Truist Financial to $49 From $51, Maintains Equalweight Rating
RBC Capital Remains a Buy on Truist Financial (TFC)
Truist Financial Sticks to Its Buy Rating for Crispr Therapeutics AG (CRSP)
Texas Capital Bancshares (TCBI) Gets a Hold From Truist Financial